Built a free AI health guidance app — here's what week 1 taught me
Hey IH,
I'm Anish, a Psychology grad from Georgia Tech currently in the CreateX accelerator. I just launched Voyage Health, a free AI health guidance app on iOS and Android.
The problem I built it for: there's a massive gap between "I feel off" and "I need to see a doctor" that nobody fills well. Google scares you. ChatGPT gives generic answers with no memory of your history. Your doctor can't see you for 2 weeks. Voyage fills that gap with structured clinical guidance, risk scoring, and follow-up tracking that persists across sessions.
Week 1 takeaways: B2C distribution is genuinely hard. LinkedIn has been the strongest channel so far. Press is moving with a local tech blog feature incoming. Reddit karma is a slow grind but worth it.
Currently bootstrapped, 160+ users, figuring it out one day at a time.
What's worked for you reaching health-conscious users at scale?
The technology is only half the equation. In healthcare, trust isn't earned by sounding intelligent it's earned by being consistently reliable when the stakes are high.
Completely agree. That's actually why we built structured output instead of open-ended chat: risk level, severity score, recommendation. It forces consistency and gives users something concrete to evaluate, but we definitely want to keep going to make sure we build that trust.
As a SaaS product owner, I completely agree. We've found that structured outputs make products much easier to validate and improve over time. Users don't just want an answer they want a consistent framework they can trust
Absolutely! And hopefully as we keep going we can make it more trustworthy and helpful to the user as we go :)
That makes a lot of sense. We've seen a similar pattern with service businesses. The biggest leak usually isn't lead generationit's what happens after the conversation starts. That's actually one of the reasons we're building Trackly. Instead of just tracking emails, it identifies conversations that have quietly become revenue opportunities, flags follow-ups that are slipping through the cracks, and helps teams prioritize the deals most likely to impact revenue. It complements the CRM by surfacing the signals that are easy to miss in a busy inbox.
That seems like a great idea! It's very hard to keep up with the amount of information people get; I'm sure Trackly will be very helpful
yes it is we are getting a good response
This is a real gap because it sits in the uncomfortable middle layer of healthcare—before diagnosis, but after uncertainty. The hardest part here won’t be AI capability, but trust: users need to believe the system is consistent, safe, and not just generating plausible medical-sounding text when they’re vulnerable.
This is definitely an important thing about Voyage and I think about it constantly. The "uncomfortable middle layer" framing is exactly right. Our approach has been restraint and bounded guidance, not open-ended diagnosis. The question is whether restraint builds trust over time or just feels limiting. Early signals are positive but it's genuinely an open question.
That's the part I found most interesting.
I don't think the bigger decision is whether restraint builds trust.
It's the strategic decision that follows if it does—or if it doesn't.
I have a few thoughts on how I'd evaluate that, but I don't think I can do them justice in a thread.
If you're open to it, what's the best email to reach you?
I'd love to hear more! You can reach me at acheekati@voyagehealth.ai
Thanks! I've just sent it over.
Looking forward to hearing your thoughts whenever you have a chance.
Also very much in week 1 territory myself right now, so a lot of this resonates — especially "B2C distribution is genuinely hard." I don't have health-specific audience experience to offer, but on the channel side, LinkedIn being your strongest early channel tracks with what I've seen too — probably the one platform where a founder posting under their own name doesn't feel out of place next to the actual content.
Congrats on the 160+ users out of the gate. Did most of that come directly from the LinkedIn posts, or more indirectly through the CreateX accelerator network?
Honestly a mix of both but LinkedIn has punched above its weight. CreateX gave us early credibility and some initial word of mouth, but the LinkedIn posts reached people outside that network who actually fit the ICP better. The founder-posting-under-their-own-name thing you mentioned is real, it removes the filter between the product and the person building it, which matters a lot in health. Appreciate the congrats, week 1 has been a learning curve more than anything.